EU5 Metered Dose Inhaler Devices Market Outlook to 2023

EU5 Metered Dose Inhaler Devices Market Outlook to 2023


  • Products Id :- GDMECR0675DB
  • |
  • Pages: 114
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

EU5 Metered Dose Inhaler Devices Market Outlook to 2023

Summary

GlobalData's new report, "EU5 Metered Dose Inhaler Devices Market Outlook to 2023", provides key market data on the EU5 Metered Dose Inhaler Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Metered Dose Inhaler Devices.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market segments.

Global corporate-level profiles of key companies operating within the EU5 Metered Dose Inhaler Devices market.

Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc and Boehringer Ingelheim GmbH.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Metered Dose Inhaler Devices Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 7

3 Metered Dose Inhaler Devices Market, EU5 8

3.1 Metered Dose Inhaler Devices Market, EU5, Revenue ($m), 2009-2023 8

3.2 Metered Dose Inhaler Devices Market, EU5, Revenue ($m), 2009-2016 10

3.3 Metered Dose Inhaler Devices Market, EU5, Revenue ($m), 2016-2023 11

3.4 Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2009-2023 12

3.5 Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2009-2016 14

3.6 Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2016-2023 15

3.7 Metered Dose Inhaler Devices Market, EU5, Company Share by Revenue ($m), 2016 16

4 Metered Dose Inhaler Devices Market, France 18

4.1 Metered Dose Inhaler Devices Market, France, Revenue ($m), 2009-2016 18

4.2 Metered Dose Inhaler Devices Market, France, Revenue ($m), 2016-2023 19

4.3 Metered Dose Inhaler Devices Market, France, Volume (Units), 2009-2016 20

4.4 Metered Dose Inhaler Devices Market, France, Volume (Units), 2016-2023 21

4.5 Metered Dose Inhaler Devices Market, France, Average Price ($), 2009-2023 22

4.6 Metered Dose Inhaler Devices Market, France, Distribution Share by Revenue ($m), 2015-2016 23

4.7 Metered Dose Inhaler Devices Market, France, Company Share by Revenue ($m), 2016 24

5 Metered Dose Inhaler Devices Market, Germany 26

5.1 Metered Dose Inhaler Devices Market, Germany, Revenue ($m), 2009-2016 26

5.2 Metered Dose Inhaler Devices Market, Germany, Revenue ($m), 2016-2023 27

5.3 Metered Dose Inhaler Devices Market, Germany, Volume (Units), 2009-2016 28

5.4 Metered Dose Inhaler Devices Market, Germany, Volume (Units), 2016-2023 29

5.5 Metered Dose Inhaler Devices Market, Germany, Average Price ($), 2009-2023 30

5.6 Metered Dose Inhaler Devices Market, Germany, Distribution Share by Revenue ($m), 2015-2016 31

5.7 Metered Dose Inhaler Devices Market, Germany, Company Share by Revenue ($m), 2016 32

6 Metered Dose Inhaler Devices Market, Italy 34

6.1 Metered Dose Inhaler Devices Market, Italy, Revenue ($m), 2009-2016 34

6.2 Metered Dose Inhaler Devices Market, Italy, Revenue ($m), 2016-2023 35

6.3 Metered Dose Inhaler Devices Market, Italy, Volume (Units), 2009-2016 36

6.4 Metered Dose Inhaler Devices Market, Italy, Volume (Units), 2016-2023 37

6.5 Metered Dose Inhaler Devices Market, Italy, Average Price ($), 2009-2023 38

6.6 Metered Dose Inhaler Devices Market, Italy, Distribution Share by Revenue ($m), 2015-2016 39

6.7 Metered Dose Inhaler Devices Market, Italy, Company Share by Revenue ($m), 2016 40

7 Metered Dose Inhaler Devices Market, Spain 42

7.1 Metered Dose Inhaler Devices Market, Spain, Revenue ($m), 2009-2016 42

7.2 Metered Dose Inhaler Devices Market, Spain, Revenue ($m), 2016-2023 43

7.3 Metered Dose Inhaler Devices Market, Spain, Volume (Units), 2009-2016 44

7.4 Metered Dose Inhaler Devices Market, Spain, Volume (Units), 2016-2023 45

7.5 Metered Dose Inhaler Devices Market, Spain, Average Price ($), 2009-2023 46

7.6 Metered Dose Inhaler Devices Market, Spain, Distribution Share by Revenue ($m), 2015-2016 47

7.7 Metered Dose Inhaler Devices Market, Spain, Company Share by Revenue ($m), 2016 48

8 Metered Dose Inhaler Devices Market, United Kingdom 50

8.1 Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), 2009-2016 50

8.2 Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), 2016-2023 52

8.3 Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), 2009-2016 53

8.4 Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), 2016-2023 54

8.5 Metered Dose Inhaler Devices Market, United Kingdom, Average Price ($), 2009-2023 55

8.6 Metered Dose Inhaler Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 56

8.7 Metered Dose Inhaler Devices Market, United Kingdom, Company Share by Revenue ($m), 2016 57

9 Overview of Key Companies in EU5 Metered Dose Inhaler Devices Market 59

9.1 GlaxoSmithKline Plc 59

9.1.1 Company Overview 59

9.2 AstraZeneca Plc 59

9.2.1 Company Overview 59

9.3 Boehringer Ingelheim GmbH 59

9.3.1 Company Overview 59

9.4 Pfizer Inc 60

9.4.1 Company Overview 60

9.5 Merck & Co Inc 60

9.5.1 Company Overview 60

10 Metered Dose Inhaler Devices Market Pipeline Products 61

11 Recent Developments 62

11.1 Corporate Communications 62

11.1.1 May 08, 2017: Dr. Stephen S. Lane joins Alcon as Chief Medical Officer and Global Head Franchise Clinical Strategy 62

11.1.2 May 01, 2017: Mylan Nominates Sjoerd Vollebregt for Election to Board of Directors 62

11.1.3 Mar 28, 2017: Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer 63

11.1.4 Mar 22, 2017: BioStable Science & Engineering Announces FDA Clearance of the HAART 300 Aortic Annuloplasty Device 63

11.1.5 Mar 06, 2017: Vectura Group: Board Change 64

11.1.6 Feb 28, 2017: Novartis shareholders approve all resolutions proposed by Board of Directors at the Annual General Meeting 65

11.1.7 Dec 14, 2016: Consort Medical: Directorate Change 65

11.1.8 Nov 25, 2016: Consort Medical: CFO Appointment 66

11.1.9 Aug 17, 2016: Consort Medical Announces Directorate Change 66

11.2 Financial Announcements 66

11.2.1 Jun 15, 2017: Consort Medical: Full year results 66

11.2.2 May 31, 2017: Lamellar Biomedical Recruits First Patients into Clinical Study Assessing LAMELLEYE for Treatment of Dry Eye Disease 67

11.2.3 May 10, 2017: Mylan Reports First Quarter 2017 Results 69

11.2.4 Apr 25, 2017: Novartis delivered sales growth across all divisions as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued 71

11.2.5 Apr 05, 2017: InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study at the Carolinas Medical Center 74

11.2.6 Apr 05, 2017: Successful financial year 2016 for Boehringer Ingelheim 74

11.2.7 Mar 29, 2017: Peer-Reviewed Clinical Study Shows ID Genomics' Bacterial Fingerprinting Technology Can Reduce Prescription Errors and Antibiotic Overuse at the Point-of-Care 75

11.2.8 Mar 21, 2017: Vectura Group: Preliminary Results for the nine-month period ended 31 December 2016 77

11.2.9 Mar 21, 2017: Vectura Group Announces Preliminary Results for the nine-month period ended 31 December 2016 79

11.2.10 Mar 01, 2017: Mylan Reports Fourth Quarter and Full Year 2016 Results and Provides 2017 Guidance 80

11.2.11 Jan 25, 2017: Novartis delivered solid 2016 performance, with Growth Products absorbing Gleevec US LOE; innovation momentum continued; announces share buyback 82

11.2.12 Dec 06, 2016: Consort Medical Reports Interim Results Results For The Six Months Ended 31 October 2016 87

11.2.13 Nov 09, 2016: Mylan Reports Third Quarter 2016 Results 88

11.2.14 Oct 25, 2016: Novartis delivered solid third quarter with Growth Products offsetting Gleevec patent expiration; several positive readouts for potential blockbusters 92

11.2.15 Aug 09, 2016: Mylan Reports Strong Second Quarter 2016 Results Including Total Revenues Up 8% 97

11.2.16 Jul 19, 2016: Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news strengthens future growth prospects 100

11.3 Other Significant Developments 105

11.3.1 Feb 16, 2017: Vectura achieves GBP 9 million royalty cap from GSK Ellipta products 105

11.3.2 Jan 26, 2017: Novartis highlights progress towards access and environmental goals in 2016 Corporate Responsibility Performance Report 105

11.3.3 Jan 26, 2017: Achievement of sales milestone for COPD products 106

11.3.4 Jan 11, 2017: Vectura Group: Pre-close update 106

11.3.5 Nov 29, 2016: Novartis Access shares one-year learnings and announces memorandum of understanding with Rwanda 107

11.3.6 Sep 07, 2016: New Scale-Up and Commercial Supply Agreement 108

11.3.7 Aug 03, 2016: Boehringer Ingelheim: Growth in all core businesses 108

12 Appendix 110

12.1 Research Methodology 111

12.1.1 Coverage 111

12.1.2 Secondary Research 111

12.1.3 Primary Research 112

12.1.4 Company Share Analysis 112

12.1.5 Distribution Share Analysis 112

12.1.6 Benchmarking 113

12.2 GlobalData Consulting 113

12.3 Contact Us 114

12.4 Disclaimer 114

1.2 List of Figures

Figure 1: Metered Dose Inhaler Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2009-2023 8

Figure 2: Metered Dose Inhaler Devices Market, EU5, Revenue ($m), Historic, USD Constant, 2009-2016 10

Figure 3: Metered Dose Inhaler Devices Market, EU5, Revenue ($m), Forecast, USD Constant, 2016-2023 11

Figure 4: Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2009-2023 12

Figure 5: Metered Dose Inhaler Devices Market, EU5, Volume (Units), Historic, 2009-2016 14

Figure 6: Metered Dose Inhaler Devices Market, EU5, Volume (Units), Forecast, 2016-2023 15

Figure 7: Metered Dose Inhaler Devices Market, EU5, Company Share (%) 2016 16

Figure 8: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 18

Figure 9: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 19

Figure 10: Metered Dose Inhaler Devices Market, France, Volume (Units), Historic, 2009-2016 20

Figure 11: Metered Dose Inhaler Devices Market, France, Volume (Units), Forecast, 2016-2023 21

Figure 12: Metered Dose Inhaler Devices Market, France, Company Share (%) 2016 24

Figure 13: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 26

Figure 14: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 27

Figure 15: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Historic, 2009-2016 28

Figure 16: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Forecast, 2016-2023 29

Figure 17: Metered Dose Inhaler Devices Market, Germany, Company Share (%) 2016 32

Figure 18: Metered Dose Inhaler Devices Market, Italy, Revenue ($m), USD Constant, Historic, 2009-2016 34

Figure 19: Metered Dose Inhaler Devices Market, Italy, Revenue ($m), USD Constant, Forecast, 2016-2023 35

Figure 20: Metered Dose Inhaler Devices Market, Italy, Volume (Units), Historic, 2009-2016 36

Figure 21: Metered Dose Inhaler Devices Market, Italy, Volume (Units), Forecast, 2016-2023 37

Figure 22: Metered Dose Inhaler Devices Market, Italy, Company Share (%) 2016 40

Figure 23: Metered Dose Inhaler Devices Market, Spain, Revenue ($m), USD Constant, Historic, 2009-2016 42

Figure 24: Metered Dose Inhaler Devices Market, Spain, Revenue ($m), USD Constant, Forecast, 2016-2023 43

Figure 25: Metered Dose Inhaler Devices Market, Spain, Volume (Units), Historic, 2009-2016 44

Figure 26: Metered Dose Inhaler Devices Market, Spain, Volume (Units), Forecast, 2016-2023 45

Figure 27: Metered Dose Inhaler Devices Market, Spain, Company Share (%) 2016 48

Figure 28: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 50

Figure 29: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 52

Figure 30: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 53

Figure 31: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 54

Figure 32: Metered Dose Inhaler Devices Market, United Kingdom, Company Share (%) 2016 57

1.1 List of Tables

Table 1: Metered Dose Inhaler Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2009-2023 9

Table 2: Metered Dose Inhaler Devices Market, EU5, Revenue ($m), Historic, USD Constant, 2009-2016 10

Table 3: Metered Dose Inhaler Devices Market, EU5, Revenue ($m), Forecast, USD Constant, 2016-2023 11

Table 4: Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2009-2023 13

Table 5: Metered Dose Inhaler Devices Market, EU5, Volume (Units), Historic, 2009-2016 14

Table 6: Metered Dose Inhaler Devices Market, EU5, Volume (Units), Forecast, 2016-2023 15

Table 7: Metered Dose Inhaler Devices Market, EU5, Company Share by Revenue ($m), USD Constant, 2016 17

Table 8: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 18

Table 9: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 19

Table 10: Metered Dose Inhaler Devices Market, France, Volume (Units), Historic, 2009-2016 20

Table 11: Metered Dose Inhaler Devices Market, France, Volume (Units), Forecast, 2016-2023 21

Table 12: Metered Dose Inhaler Devices Market, France, Average Price ($), Historic, 2009-2016 22

Table 13: Metered Dose Inhaler Devices Market, France, Average Price ($), Forecast, 2016-2023 22

Table 14: Metered Dose Inhaler Devices Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016 23

Table 15: Metered Dose Inhaler Devices Market, France, Company Share by Revenue ($m), USD Constant, 2016 25

Table 16: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 26

Table 17: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 27

Table 18: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Historic, 2009-2016 28

Table 19: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Forecast, 2016-2023 29

Table 20: Metered Dose Inhaler Devices Market, Germany, Average Price ($), Historic, 2009-2016 30

Table 21: Metered Dose Inhaler Devices Market, Germany, Average Price ($), Forecast, 2016-2023 30

Table 22: Metered Dose Inhaler Devices Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016 31

Table 23: Metered Dose Inhaler Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2016 33

Table 24: Metered Dose Inhaler Devices Market, Italy, Revenue ($m), USD Constant, Historic, 2009-2016 34

Table 25: Metered Dose Inhaler Devices Market, Italy, Revenue ($m), USD Constant, Forecast, 2016-2023 35

Table 26: Metered Dose Inhaler Devices Market, Italy, Volume (Units), Historic, 2009-2016 36

Table 27: Metered Dose Inhaler Devices Market, Italy, Volume (Units), Forecast, 2016-2023 37

Table 28: Metered Dose Inhaler Devices Market, Italy, Average Price ($), Historic, 2009-2016 38

Table 29: Metered Dose Inhaler Devices Market, Italy, Average Price ($), Forecast, 2016-2023 38

Table 30: Metered Dose Inhaler Devices Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2015-2016 39

Table 31: Metered Dose Inhaler Devices Market, Italy, Company Share by Revenue ($m), USD Constant, 2016 41

Table 32: Metered Dose Inhaler Devices Market, Spain, Revenue ($m), USD Constant, Historic, 2009-2016 42

Table 33: Metered Dose Inhaler Devices Market, Spain, Revenue ($m), USD Constant, Forecast, 2016-2023 43

Table 34: Metered Dose Inhaler Devices Market, Spain, Volume (Units), Historic, 2009-2016 44

Table 35: Metered Dose Inhaler Devices Market, Spain, Volume (Units), Forecast, 2016-2023 45

Table 36: Metered Dose Inhaler Devices Market, Spain, Average Price ($), Historic, 2009-2016 46

Table 37: Metered Dose Inhaler Devices Market, Spain, Average Price ($), Forecast, 2016-2023 46

Table 38: Metered Dose Inhaler Devices Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2015-2016 47

Table 39: Metered Dose Inhaler Devices Market, Spain, Company Share by Revenue ($m), USD Constant, 2016 49

Table 40: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 51

Table 41: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 52

Table 42: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 53

Table 43: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 54

Table 44: Metered Dose Inhaler Devices Market, United Kingdom, Average Price ($), Historic, 2009-2016 55

Table 45: Metered Dose Inhaler Devices Market, United Kingdom, Average Price ($), Forecast, 2016-2023 55

Table 46: Metered Dose Inhaler Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 56

Table 47: Metered Dose Inhaler Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 58

Table 48: Metered Dose Inhaler Devices Market Pipeline Products 61

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

GlaxoSmithKline Plc

AstraZeneca Plc

Boehringer Ingelheim GmbH

Pfizer Inc

Merck & Co Inc

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

select a license

Single User License
USD 5995 INR 401185
Site License
USD 11990 INR 802371
Corporate User License
USD 17985 INR 1203556

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com